US 7067482
Cross-linked glycopeptide-cephalosporin antibiotics
granted A61PA61P11/00A61P13/02
Quick answer
US patent 7067482 (Cross-linked glycopeptide-cephalosporin antibiotics) held by Theravance, Inc. expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61P, A61P11/00, A61P13/02, A61P17/00, A61P19/00